Cargando…

Elderly sarcoidosis in Japan

OBJECTIVE: The manifestations of sarcoidosis differ by ethnicity and region. However, the few studies that have focused on elderly sarcoidosis are only from Western countries. Therefore, we investigated elderly sarcoidosis in Japan. METHODS: We retrospectively reviewed the records of adult patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Masumoto, Nami, Watanabe, Keisuke, Horita, Nobuyuki, Hara, Yu, Kobayashi, Nobuaki, Kaneko, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793039/
https://www.ncbi.nlm.nih.gov/pubmed/36562117
http://dx.doi.org/10.1177/03000605221142705
_version_ 1784859768595152896
author Masumoto, Nami
Watanabe, Keisuke
Horita, Nobuyuki
Hara, Yu
Kobayashi, Nobuaki
Kaneko, Takeshi
author_facet Masumoto, Nami
Watanabe, Keisuke
Horita, Nobuyuki
Hara, Yu
Kobayashi, Nobuaki
Kaneko, Takeshi
author_sort Masumoto, Nami
collection PubMed
description OBJECTIVE: The manifestations of sarcoidosis differ by ethnicity and region. However, the few studies that have focused on elderly sarcoidosis are only from Western countries. Therefore, we investigated elderly sarcoidosis in Japan. METHODS: We retrospectively reviewed the records of adult patients (≥18 years old) who were diagnosed with sarcoidosis from 1 April 2006 to 31 March 2020. The diagnosis was pathologically confirmed in all patients. We compared the clinical features of elderly (diagnosed at ≥65 years old) and non-elderly (diagnosed at <65 years old) patients. RESULTS: Thirty-five (33%) of 106 patients were elderly. The elderly group had significantly more comorbidities than the non-elderly group (median [range], 1 [0–4] vs. 0 [0–5]). The biopsy site at diagnosis included significantly more extrathoracic sites in the elderly than non-elderly group (57.1% vs. 33.8%). The elderly group had significantly more muscle lesions than the non-elderly group at the time of diagnosis (11.4% vs. 1.4%) and at any time during follow-up (17.1% vs. 1.4%). CONCLUSION: In Japan, elderly patients with sarcoidosis might have more muscle involvement and comorbidities than younger patients. Because comorbidities might affect the prognosis of elderly sarcoidosis, further study is needed to clarify the effect of comorbidities on elderly sarcoidosis.
format Online
Article
Text
id pubmed-9793039
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-97930392022-12-28 Elderly sarcoidosis in Japan Masumoto, Nami Watanabe, Keisuke Horita, Nobuyuki Hara, Yu Kobayashi, Nobuaki Kaneko, Takeshi J Int Med Res Retrospective Clinical Research Report OBJECTIVE: The manifestations of sarcoidosis differ by ethnicity and region. However, the few studies that have focused on elderly sarcoidosis are only from Western countries. Therefore, we investigated elderly sarcoidosis in Japan. METHODS: We retrospectively reviewed the records of adult patients (≥18 years old) who were diagnosed with sarcoidosis from 1 April 2006 to 31 March 2020. The diagnosis was pathologically confirmed in all patients. We compared the clinical features of elderly (diagnosed at ≥65 years old) and non-elderly (diagnosed at <65 years old) patients. RESULTS: Thirty-five (33%) of 106 patients were elderly. The elderly group had significantly more comorbidities than the non-elderly group (median [range], 1 [0–4] vs. 0 [0–5]). The biopsy site at diagnosis included significantly more extrathoracic sites in the elderly than non-elderly group (57.1% vs. 33.8%). The elderly group had significantly more muscle lesions than the non-elderly group at the time of diagnosis (11.4% vs. 1.4%) and at any time during follow-up (17.1% vs. 1.4%). CONCLUSION: In Japan, elderly patients with sarcoidosis might have more muscle involvement and comorbidities than younger patients. Because comorbidities might affect the prognosis of elderly sarcoidosis, further study is needed to clarify the effect of comorbidities on elderly sarcoidosis. SAGE Publications 2022-12-22 /pmc/articles/PMC9793039/ /pubmed/36562117 http://dx.doi.org/10.1177/03000605221142705 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Creative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Retrospective Clinical Research Report
Masumoto, Nami
Watanabe, Keisuke
Horita, Nobuyuki
Hara, Yu
Kobayashi, Nobuaki
Kaneko, Takeshi
Elderly sarcoidosis in Japan
title Elderly sarcoidosis in Japan
title_full Elderly sarcoidosis in Japan
title_fullStr Elderly sarcoidosis in Japan
title_full_unstemmed Elderly sarcoidosis in Japan
title_short Elderly sarcoidosis in Japan
title_sort elderly sarcoidosis in japan
topic Retrospective Clinical Research Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9793039/
https://www.ncbi.nlm.nih.gov/pubmed/36562117
http://dx.doi.org/10.1177/03000605221142705
work_keys_str_mv AT masumotonami elderlysarcoidosisinjapan
AT watanabekeisuke elderlysarcoidosisinjapan
AT horitanobuyuki elderlysarcoidosisinjapan
AT harayu elderlysarcoidosisinjapan
AT kobayashinobuaki elderlysarcoidosisinjapan
AT kanekotakeshi elderlysarcoidosisinjapan